TEXT-S&P cuts Pharmaceutical Product Development to ‘B’

Overview — Wilmington, N.C.-based contract research organization (CRO) Pharmaceutical Product Development LLC (PPD) is issuing $500 million in notes that, together with $115 million in cash, the company will use to fund a sponsor dividend.

Share

TEXT-S&P cuts Pharmaceutical Product Development to ‘B’

Overview — Wilmington, N.C.-based contract research organization (CRO) Pharmaceutical Product Development LLC (PPD) is issuing $500 million in notes that, together with $115 million in cash, the company will use to fund a sponsor dividend.

Share